Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants

Abstract

by Barbara K. Burton,Joel Charrow,George E. Hoganson,Julie Fleischer,Dorothy K. Grange,Stephen R. Braddock,Lauren Hitchins,Rachel Hickey,Katherine M. Christensen,Daniel Groepper,Heather Shryock,Pamela Smith,Rong Shao andKhaja Basheeruddin
Int. J. Neonatal Screen. 2020, 6(1), 4; https://doi.org/10.3390/ijns6010004 - 17 july 2022
Cited by 24 | Viewed by 4793
Abstract
Statewide newborn screening for Pompe disease began in Illinois in 2015. As of 30 September 2019, a total of 684,290 infants had been screened and 395 infants (0.06%) were screen positive. A total of 29 cases of Pompe disease were identified (3 infantile, 26 late-onset). While many of the remainder were found to have normal alpha-glucosidase activity on the follow-up testing (234 of 395), other findings included 62 carriers, 39 infants with pseudodeficiency, and eight infants who could not be given a definitive diagnosis due to inconclusive follow-up testing. Full article
(This article belongs to the Special Issue Newborn Screening for Pompe Disease)
► Show Figures
2 pages, 191 KiB
Open AccessEditorial